Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
$2.90
-1.0%
$4.35
$2.79
$135.54
$2.35M-0.28459,733 shs231,041 shs
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.26
-3.1%
$1.83
$0.90
$6.80
$65.01M-0.821.76 million shs96,893 shs
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
$2.15
+5.4%
$1.65
$0.95
$2.97
$18.31M0.05370,180 shs209,944 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.05
-24.6%
$0.04
$0.75
$1.65
$1.20M-0.88708,132 shs30,755 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
-0.68%-1.35%-19.73%-67.44%-91.65%
Agape ATP Corporation stock logo
ATPC
Agape ATP
-5.11%-10.34%-36.89%+26.21%-70.45%
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
+3.03%+3.55%+4.08%+65.18%-30.85%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
+20.00%+41.18%+81.82%-70.00%-97.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
2.4654 of 5 stars
3.52.00.00.01.14.20.0
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.3406 of 5 stars
0.05.00.00.00.60.00.0
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
1.3592 of 5 stars
0.04.00.03.42.50.00.6
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
3.00
Buy$180.006,106.90% Upside
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
0.00
N/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
N/AN/AN/AN/A($31.66) per shareN/A
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M47.74N/AN/A$0.48 per share2.63
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
$81M0.24N/AN/A$4.64 per share0.46
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$15.22M0.08N/AN/A$0.69 per share0.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
-$9.95MN/A0.00N/AN/AN/A-497.73%-147.21%7/29/2025 (Estimated)
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.60N/AN/A-191.34%-30.95%-27.00%8/12/2025 (Estimated)
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
-$15.84M-$0.72N/AN/A2.37%3.51%0.91%N/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
-$10.54MN/A0.00N/AN/A-75.40%-52.17%-34.51%N/A

Latest IMAC, AYTU, ATPC, and ALZN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/14/2025Q3 2025
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
-$0.17$0.20+$0.37$0.21$13.74 million$18.45 million
3/31/2025Q4 2024
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
N/AN/AN/AN/AN/A
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
N/A
5.44
5.44
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
24.68
24.64
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
0.27
1.03
0.87
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.01
1.27
1.27

Institutional Ownership

CompanyInstitutional Ownership
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
49.61%
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
33.49%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
24.27%

Insider Ownership

CompanyInsider Ownership
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
30.21%
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
3.60%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alzamend Neuro, Inc. stock logo
ALZN
Alzamend Neuro
4800,000559,000No Data
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Aytu BioPharma Inc. stock logo
AYTU
Aytu BioPharma
1608.98 million8.65 millionNot Optionable
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10626.49 million23.84 millionNot Optionable

Recent News About These Companies

History of the eMac

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alzamend Neuro stock logo

Alzamend Neuro NASDAQ:ALZN

$2.90 -0.03 (-1.02%)
Closing price 04:00 PM Eastern
Extended Trading
$2.88 -0.02 (-0.86%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.26 -0.04 (-3.08%)
Closing price 03:59 PM Eastern
Extended Trading
$1.26 +0.00 (+0.40%)
As of 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Aytu BioPharma stock logo

Aytu BioPharma NASDAQ:AYTU

$2.15 +0.11 (+5.39%)
Closing price 04:00 PM Eastern
Extended Trading
$2.13 -0.02 (-0.93%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR, and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

IMAC stock logo

IMAC NASDAQ:IMAC

$0.05 -0.01 (-24.65%)
As of 06/24/2025

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.